VDC2008

Developed for: prostate cancer
Investigated by: Bostwick Laboratories · Community Memorial HealthCenter · HemaCare Corporation · Prostate Institute of America

today NCT00753220 · Ph 1/2

201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT00753220	Aug 2009 → May 2011	prostate cancer	Bostwick Laboratories	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	VDC2008	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00753220 ↗
Route	Other	“Intratumoral injection of VDC2008 post-cryotherapy.” NCT00753220 ↗